Profile picture

Doctor Tim Anthonie Christiaan de Vries

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))
Membership: ESC Professional Member
Follow
Biography
Tim A.C. de Vries is a medical doctor, currently working at the Amsterdam UMC location AMC as a PhD candidate/physician-scientist. With his research he aims to provide further insights into the use of oral anticoagulation in patients with atrial fibrillation in routine clinical practice, as well as into the role of inflammation in this common arrhythmia.
Logo ESC

Contributor content

Edoxaban for stroke prevention in routine practice patients with atrial fibrillation with and without atherosclerotic disease: a post-hoc sub-study of ETNA-AF-Europe
Presentation
Edoxaban for stroke prevention in routine practice patients with atrial fibrillation with and without atherosclerotic disease: a post-hoc sub-study of ETNA-AF-Europe
Perceived frailty and clinical outcomes in men and women with atrial fibrillation treated with edoxaban: insights from the 2-year follow-up of ETNA-AF-Europe
Presentation
Perceived frailty and clinical outcomes in men and women with atrial fibrillation treated with edoxaban: insights from the 2-year follow-up of ETNA-AF-Europe
The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe
Presentation
The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe
Outcomes of edoxaban-treated patients with atrial fibrillation and concomitant vascular disease in daily clinical practice: insights from ETNA-AF-Europe
Presentation
Outcomes of edoxaban-treated patients with atrial fibrillation and concomitant vascular disease in daily clinical practice: insights from ETNA-AF-Europe

ESC 365 is supported by